U.S. Other Utilities Stock News

Venture Global (VG) has drawn investor attention after a recent share pullback, with a 1 day return of about 1.7% and a 7 day decline near 20%, following a strong past 3 months. See our latest analysis for Venture Global. That pullback sits against a strong backdrop, with an 81.11% year to date share price return and a 52.40% 1 year total shareholder return. This suggests earlier momentum is now cooling as investors reassess growth prospects and risks around the current US$12.75 level. If you...

If you are wondering whether Innovative Industrial Properties is attractively priced or not, the first step is to look closely at what the current share price is really offering you. The stock recently closed at US$50.68, with returns of 2.5% over 7 days, a 3.8% decline over 30 days, a 2.4% gain year to date, a 15.4% gain over 1 year, a 3.5% decline over 3 years, and a 57.2% decline over 5 years. Recent news around the company has focused on its position in the specialized real estate space...

Virtu Financial (VIRT) has quickly come into focus after strong earnings revisions, upbeat broker commentary on the upcoming quarter, and recent financial results that featured sustained profitability, dividends, and meaningful share repurchases. See our latest analysis for Virtu Financial. That optimism has been reflected in the share price, with a 30.2% 1 month share price return and a 49.5% 3 month share price return feeding into a 56.1% year to date gain and a 3 year total shareholder...

Why Catalyst Pharmaceuticals Is On Investors’ Radar Catalyst Pharmaceuticals (CPRX) has drawn fresh attention after recent trading, with the share price closing at $25.34. Investors are weighing this level against the company’s current earnings profile and rare disease focus. See our latest analysis for Catalyst Pharmaceuticals. The 1-day share price return of 1.6% builds on a 30-day share price return of 9.1% and a three year total shareholder return of 40.2%, pointing to momentum that has...

GM (NYSE:GM) has issued a series of recalls, including more than 270,000 Chevrolet Malibu vehicles. The company also recalled nearly 33,000 Chevrolet Corvettes, adding to recent quality and compliance actions. GM has resumed development of the GMC Jimmy SUV and is altering production plans for the Chevrolet Blazer. For investors following GM, these announcements relate directly to the core of the business: mass market autos, premium performance cars, and SUVs. Recalls can influence brand...

Amgen (NasdaqGS:AMGN) and Zai Lab have agreed to a global clinical trial collaboration focused on small cell lung cancer. The partnership will evaluate a combination of two DLL3 targeting therapies, Amgen's IMDELLTRA and Zai Lab’s zocilurtatug pelitecan. This is described as a first of its kind combination of a BiTE therapy and an antibody drug conjugate in this setting. Amgen, trading at $349.82, has seen its share price move 2.1% over the past week and 6.8% year to date, with a 22.8%...

Aeluma (ALMU) is back on investor radars after securing more than US$4 million in U.S. Government contracts to advance its semiconductor heterogeneous integration platform for quantum and high speed datacom applications. See our latest analysis for Aeluma. The shares have been volatile, with a 42.66% 1 day share price return and 30.81% 7 day share price return lifting the latest price to US$15.35. Over a 90 day period the share price return is a 32.08% decline, while the 3 year total...

What recent returns signal for Blackstone Mortgage Trust Blackstone Mortgage Trust (BXMT) has drawn investor attention after a series of recent returns, including a 0.9% move over the past day and gains across the past week, month, and past 3 months. See our latest analysis for Blackstone Mortgage Trust. At a share price of $19.78, Blackstone Mortgage Trust has paired a 6.9% 7 day share price return with a 20.6% 1 year total shareholder return, suggesting recent momentum has added to longer...

Air Products and Chemicals (APD) has been drawing investor attention after recent share price moves, with the stock showing returns over the past month and past 3 months, prompting closer scrutiny of its current valuation. See our latest analysis for Air Products and Chemicals. Recent share price momentum has been building, with a 30 day share price return of 3.71% and a 90 day share price return of 12.20%, while the 1 year total shareholder return of 12.50% points to steadier long term...

A. O. Smith (AOS) has attracted attention after recent share price moves, with the stock up about 1.9% over the past day and 3.9% over the past week, prompting closer scrutiny from investors. See our latest analysis for A. O. Smith. While the recent 1-day and 7-day share price returns suggest short-term momentum, the 90-day share price return of 4.8% and modest multi year total shareholder returns indicate a more muted longer term picture. If this kind of steady industrial name is on your...

With Newmont shares at US$116.50, many investors are asking the same question: does that price still reflect fair value, or has the stock run ahead of its fundamentals? Newmont has seen strong share price performance, with returns of 3.3% over the last week, 6.3% over the last month, 15.1% year to date, 115.4% over the last year, 158.7% over three years and 108.7% over five years, which naturally puts the current valuation under the spotlight. Recent coverage of Newmont has focused on its...

Why Braze Stock Is On Investors’ Radar Today Braze (BRZE) has been drawing fresh attention after a volatile few months, with the share price recently closing at US$20.61 and returns over the past year and past 3 months in negative territory. See our latest analysis for Braze. The recent 1 day share price return of 8.65% comes after a 30 day share price return of 9.80%. However, the year to date share price return of negative 36.68% and 1 year total shareholder return of negative 27.25%...

AbbVie (ABBV) is back in focus after releasing late breaking Phase 2 data for ELAHERE combined with carboplatin in recurrent platinum sensitive ovarian cancer, highlighting response rates and safety outcomes in a difficult to treat population. See our latest analysis for AbbVie. Despite the positive attention around ELAHERE data and the recent Haisco pain-drug licensing deal, AbbVie’s 30-day share price return of a 6.01% decline and year-to-date share price return of a 9.96% decline suggest...

ServiceNow (NYSE:NOW) and Qlik announced a new partnership to connect governed enterprise data with workflow execution inside the ServiceNow platform. The collaboration aims to bring Qlik analytics and governance directly into ServiceNow workflows, supporting AI driven insights where work actually gets done. The move is positioned as a way to link enterprise wide operational signals with day to day automation decisions inside ServiceNow. For you as an investor, this partnership reflects how...

Representative April McClain Delaney recently bought shares of Martin Marietta Materials (NYSE:MLM). The transaction involves a sitting member of Congress, drawing attention to the company and its current valuation. The purchase comes as Martin Marietta Materials trades around $635.29 per share. Martin Marietta Materials, trading on the NYSE under the ticker MLM, sits at a share price of about $635.29. The stock has returned 6.2% over the past week, 8.8% over the past month, and 27.0% over...

In the fourth quarter and full year ended January 31, 2026, RH reported higher sales and net income year over year, while also disclosing operational headwinds from larger-than-expected backorder and special-order balances tied to tariffs and adverse weather. These results have drawn legal scrutiny over potential securities law issues even as easing geopolitical tensions and lower oil prices improved the cost outlook for retailers such as RH. Next, we’ll examine how easing fuel and shipping...

Eli Lilly's Jaypirca (pirtobrutinib) achieved positive Phase 3 results in chronic lymphocytic leukemia and small lymphocytic lymphoma. The late stage trial showed that Jaypirca, combined with other therapies, improved progression free survival for patients. The data could support a regulatory submission this year to expand Jaypirca's approved uses beyond its current label. Eli Lilly (NYSE:LLY), trading at $929.55 at the last close, is widely associated with its GLP 1 obesity and diabetes...

Webull (BULL) has drawn fresh attention after Webull Canada introduced zero commission trading for U.S. and Canadian equities. This coincides with record revenue disclosures and heavier marketing spend in its latest annual report. See our latest analysis for Webull. The recent launch of zero commission trading and the latest annual report have come alongside a 1-day share price return of 7.1% and a 7-day share price return of 6.9%. However, Webull’s year to date share price return of 35.5%...

The US FDA refused to file Replimune’s application for its experimental skin cancer drug in combination with Bristol Myers Squibb’s Opdivo for advanced melanoma. The decision was based on concerns about the study design rather than detailed efficacy or safety findings. This affects a collaboration that sits within Bristol Myers Squibb’s core immuno oncology efforts around NYSE:BMY’s Opdivo franchise. Bristol Myers Squibb, trading as NYSE:BMY, is a large biopharmaceutical company with a...

Credo Technology Group Holding (NasdaqGS:CRDO) has entered a definitive agreement to acquire DustPhotonics, a Silicon Photonics developer focused on optical connectivity. The deal expands Credo's reach from electrical interconnects into optical solutions for AI and cloud data centers. The transaction is expected to influence future product offerings, market reach, and Credo's role in AI infrastructure connectivity. For you as an investor, this move puts NasdaqGS:CRDO directly into the...

Fresh Del Monte Produce (NYSE:FDP) recently reported strong quarterly earnings, highlighting solid profitability in the most recent period. At the same time, the company continues to face long running revenue stagnation, a weaker revenue outlook, and structural profitability pressures. These mixed signals are raising questions about how sustainable the latest results may be without deeper business changes. Fresh Del Monte Produce, a global supplier of fresh and fresh cut fruits and...

Palomar Holdings (PLMR) is back on traders’ screens after a price target hike and reaffirmed Outperform rating from Keefe, Bruyette & Woods, a move that coincides with generally positive analyst sentiment. See our latest analysis for Palomar Holdings. Recent trading reflects that renewed optimism, with a 5.35% 7 day share price return and a 6.81% 30 day share price return, set against a year to date share price decline of 2.61% and a three year total shareholder return of 139.07%. This...

Floor & Decor Holdings (FND) is drawing investor attention after opening a new warehouse store and design center in the Portland metro area, extending its footprint beyond 270 warehouse-format locations nationwide. See our latest analysis for Floor & Decor Holdings. While the new Portland warehouse highlights ongoing expansion, the share price tells a different story, with a 30 day share price return of an 11.93% decline and a 1 year total shareholder return of a 31.27% decline. This suggests...

In early April 2026, Penguin Solutions, Inc. reported second-quarter results showing lower revenue of US$343 million year on year but sharply higher net income of US$37.45 million and raised its full-year 2026 outlook to target 12% year over year net sales growth (plus or minus 5%) and diluted EPS of US$1.30 (plus or minus US$0.15). The company also filed employee stock ownership plan-related shelf registrations and saw several pre-planned insider stock sales, developments that contrast with...